ACTIV-6 Trial Studies Three Drugs, Including Ivermectin as Treatment for Covid-19
A trial led by the Duke Clinical Research Institute in North Carolina and other health facilities such as the Medical University of South Carolina (MUSC) began a new clinical trial open for everyone 30 years or older. The trial will…